Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2002; 88(02): 361-362
DOI: 10.1055/s-0037-1613213
DOI: 10.1055/s-0037-1613213
Letters to the Editor
Inhibition of Human Osteoblast Growth by Unfractionated Heparin and by Low Molecular Weight Heparins in vitro
Further Information
Publication History
Received
22 February 2002
Accepted after resubmission
07 May 2002
Publication Date:
07 December 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/200202/lookinside/thumbnails/10-1055-s-0037-1613213-1.jpg)
Abbreviations: LMWHs: Low molecular weight heparins, UFH: Unfractionated heparin
-
References
- 1 Griffith GC, Nichols jr G, Asher JD, Flanagan B. Heparin Osteoporosis. JAMA 1965; 193: 85-8.
- 2 Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynaecol 1993; 168: 1265-70.
- 3 Monreal M, Lafoz E, Olive A, del-Rio L, Vedia C. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin in patients with venous thromboembolism and contraindications to coumarin. Thromb Haemost 1994; 71: 7-11.
- 4 Bhandari M, Hirsh J, Weitz JI, Young E, Venner TJ, Shaugnessy SG. The effects of standard and low molecular weight heparin on bone nodule formation in vitro. Thromb Haemost 1998; 80: 413-7.
- 5 Hurley MM, Kream BE, Raisz LG. Structural Determinants of Capacity of Heparin to Inhibit Collagen Synthesis in 21-Day Fetal Rat Calvaria. J Bone Miner Res 1990; 05: 1127-33.
- 6 Robey PG, Termine JD. Human bone cells in vitro. Calcif Tissue Int 1985; 37: 453-60.
- 7 Farley JR, Hall SL, Tanner MA, Wergedal JE. Specific activity of skeletal alkaline phosphatase in human osteoblast-line cells regulated by phosphatase, phosphatase esters and phosphatase analogies and release of alkaline phosphatase activity inversely regulated by calcium. J Bone Miner Res 1994; 09: 497-508.
- 8 Shaughnessy SG, Young E, Deschamps P, Hirsh J. The Effects of Low Molecular Weight and Standard Heparin on Calcium Loss from Fetal Rat Calvaria. Blood 1995; 86: 1368-73.
- 9 Fareed J, Jeske W, Hoppensteadt D, Clarizio R, Walenga JM. Are the available low molecular weight heparin-preparations the same?. Sem Thromb Hemost 1996; 22: 77-91.
- 10 Nelson-Piercy C. Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis. Baillieres Clin Obstet Gynacol 1997; 11: 489-509.
- 11 Sivakumaran M, Gosh K, Zaidi Y, Hutchinson RM. Osteoporosis and vertebral collapse following low-dose low molecular weight heparin therapy in a young patient. Clin Lab Haematol 1996; 18: 55-7.